As reported in GenomeWeb, June 24, 2022:
University of Maryland Medicine (UMM), a joint enterprise of the University of Maryland Medical School and University of Maryland Medical System, has launched the My Healthy Maryland precision medicine research study. The project aims to enroll 250,000 Maryland residents over the next decade, with a particular focus on underserved populations who experience significant health disparities. As part of the effort, researchers will collect broad health data, including genetic information, to help better understand human genomic variation and its relationship to disease and treatment. As previously reported, UMM partnered with digital health research company Vibrent Health to host the study on Vibrent’s Digital Health Research Platform, which is designed to recruit and engage diverse research participants and take in data from surveys, genomics, biosamples, electronic health records, wearables, and other sources.